• Explore /
  • Poster
  • / MONEO: A phase II study of avelumab (Av) plus FLOT in the peri-operative treatment for patients (pts) with resectable gastric or gastroesophageal junction cancer (GC).

MONEO: A phase II study of avelumab (Av) plus FLOT in the peri-operative treatment for patients (pts) with resectable gastric or gastroesophageal junction cancer (GC).

Abstract Poster

Authors

MARIA ALSINA

MARIA ALSINA

Vall d'Hebron Institute of Oncology, Barcelona, Spain

MARIA ALSINA , Mariano Ponz-Sarvise , Dario Lopez Garcia , Marta Gonzalez , Carlos E De Andrea , Alena Gros , Ana Vivancos , Paula Jiménez-Fonseca , Marc Diez Garcia , Virginia Arrazubi , Enrique Sanz-Garcia , Eva Martínez de Castro , Raquel Guardeno , Mariona Calvo , Cristina Buges , Federico Longo , Josep Tabernero , Guillermo Villacampa , Susana Muñoz , Ignacio Melero

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer

Clinical Trial Registration Number

NCT03979131

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr TPS4155)

DOI

10.1200/JCO.2021.39.15_suppl.TPS4155

Abstract #

TPS4155

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Ning Li

First Author: Yelena Y. Janjigian

First Author: Hongli Li

Poster

2018 ASCO Annual Meeting

Iconic: Peri-operative immuno-chemotherapy in operable oesophageal and gastric cancer.

Iconic: Peri-operative immuno-chemotherapy in operable oesophageal and gastric cancer.

First Author: Sonia Mansukhani